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Rapid development of a new methodology is not altogether
unusual in the current environment of diagnostic and inter-
ventional cardiology
. Remarkable benefits might be pro-
jected, but scientists and clinicians alike must first develop
an adequate understanding of the method's advantages and
limitations . Myocardial contrast two-dimensional echocar-
diography represents a promising new diagnostic technique
that has undergone extensive experimental validations as
well as recent clinical trials
. The preceding article in this
issue of the Journal by Keller of al . (I) deals with an
interesting application of contrast echocardiography and
joins the growing literature in this field
.
Progress in contrast echocardiography . After early explo-
ration (2,3), the Journal of the American College of Cardiol-
ogy published in 1984 a seminar (4) featuring articles on echo
contrast agents, assessment of ischemic risk zones and study
of regional myocardial blood flow and function, by myocar-
dial contrast echocardiography. Despite encouraging prog-
ress, the need was recognized to develop contrast agents as
quantitative microcirculatory tracers, standardize intracoro-
nary or alternate injections and enhance the echo image
quality that underlies valid tissue contrast analysis . Signifi-
cant recent developments include sonicated or other agents
containing extremely small microbubbles (3 to 5 yam) to he
uniformly distributed and delivered in optimal concentra-
tions (5,6) . Computer-aided methods now permit dynamic
study of myocardial contrast appearance-disappearance,
yielding several potential indexes of perfusion (7) . In recog-
nition of current limitations, efforts are under way to develop
dedicated ultrasound instrumentation
(8)
. Contrast echocar-
diography is particularly well suited for detection and delin-
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cation of severely underperfused ml ocardium . for example .
after coronary occlusion (9) .
In the catheterization labora-
mry, when contrast echocardiography (with 2 ml intracoro-
nary sonicated Renografin-76) was performed on patients
with normal coronary arteries . anatomically corresponding
myocardial regions were satisfactorily delineated (10) . This
technique defines underperfused myocardiun . distal to all
angiographicolly demonstrated severe coronary artery lesion
and indicates a return of regional perfusion after successful
vessel dilation by angioplasty (II)
.
Clinical contrast echo-
cardiographic quantitation of myocardial blood flow remains
to be demonstrated, but this ultimate goal seemed attainable
in experiments with the use of new echo contrast agents and
dynamic analysis (12).
Is myocardial contrast echocardiography really necessary?
The question might he asked whether this method provides
significantly more information than that obtained through
fully noninvasive two-dimensional eehocardiographic mea-
serements of regional wall motion- The answer is that .
although severe underperfusion is generally associated with
severe dysfunction, there are exceptions and dissociation
(for example, in early reperfusionl . The extent and config-
uration of underperfused myocardium may not be ade-
quately defined by the area of dysfunction . With regard to
the site and severity of vessel stenosis, myocardial blood
flow clearly depends on the input from the epicardial coro-
nary arteries, but other factors (for example, cardiac con-
traction) also have a major effect . The primary physiologic
determinants of myocardial survival, that is, the level and
distribution of tissue blood flow, may not be fully described
by the severity of the coronary lesions . Therefore, myocar-
dial perfusion measurements should supplement evaluation
of coronary arteries and assessment of regional contractile
function . In comparison with other promising techniques
.
contrast echocardiography combines real time tomographic
imaging with good resolution
. significant economy, flexi-
bility of application and minimal toxicity.
Myocardial contrast echocardlographic characterization of
coronary stenoses . Feinstein et al . (13) used intracoronary
sonicated Renografin-76 without complications in 50 patients
in the absence of or with significant coronary lesions . Case
descriptions indicated that perfusion deficiencies may be
evident in some patients even in the preslace of normal
coronary arteries . After arteriography, Griffin et al . (l4)
studied regional myocardial echo intensities in 28 patients
with normal or diseased coronary arteries . Intracoronary
hand-agitated Renografin-76 injection allowed safe and re
producible study of perfpsion zones, but myocardial en-
hancement was too heterogeneous to permit quantitative
evaluation of moderate coronary stenoses. Ten Cate et al .
(15) applied videodensitometric contrast echocardiogtaphic
0735.1097188153 . .50
9 36
	
MEEROAVM
EDITORIAL COMMENT
analysis of myocardial regions visualized in apical four
chamber views of the left ventricle
. Using intracoronary
sonicated iopamidol in 12 patients with a wide range of single
vessel stenosis, these investigators found a significant cor-
relation between area under the echocardiographic intensity-
time curve and percent coronary artery stenosis .
Evaluation of functional significance of coronary lesions .
Because myocardial blood flow may not become impaired
until a coronary artery is severely constricted, study of the
functional significance of moderate coronary lesions is best
accomplished by measuring the coronary reserve or poten-
tiation of regional myocardial perfusion in the presence of
pharmacologically induced hyperemia, for example, by irt-
tracoronary papaverine . Cheiriff et al
. (16) studied 40 pa-
tients, of whom 27 had various coronary lesions and 13 had
normal coronary arteries. Contrast echocardiography was
perforated before and 10 to 15 s after administration of 8 to
10 mg intracoronary papaverine . Peak regional myocardial
echo intensities increased significantly after papaverine in
the normal coronary subset, but remained unchanged in
patients with angiographically demonstrated lesions
.
Two advantages of the smaller (nine patients) study by
Keller et a1 . (1) in this issue of the Journal are that it was
limited to patients with single vesse! stenosis and it com-
pared in each patient the 45 s posipapaverine effects in
myocardial territories supplied by stenotic versus normal
coronary arteries. Before papaverine, the stenotic and nor-
mal arteries yielded equivalent myocardial contrast enhance-
ment
. After papaverine, major enhancement was noted only
distal to the normal vessel, and contrast echocardiography
clearly defined a lower perfusion zone . In equivalent animal
experiments, the peak myocardial contrast intensity index
was highly variable and correlated poorly with myocardial
blood flow measured by radioactive microspheres
. This
finding might be ascribed to factors related to contrast or
ultrasound . Pre to early postpapaverine changes in area
under the intensity-time curve correlated significantly with
corresponding alterations in regional myocardial blood flow
.
For obvious reasons, similar validations could not be per-
formed clinically. The authors (I) discussed mechanisms and
methodologic issues, some of which still preclude absolute
measurements of myocardial perfusion . Additional studies in
larger patient subsets must also examine the more complex
discrimination anticipated with multiple and perhaps less
severe coronary artery stenoses . Although experimental and
clinical reports (17
.18) reinforce the current perception of
the safety and minimal toxicity of myocardial contrast echo-
cardiography, wary vigilance regarding safety must con-
tinue, particularly when cardiac function is depressed . Fu-
ture use ofbenign echo contrast agents with extremely small
microbubbles, further standardization of injections and so-
phisticated imaging with ultrasound systems with expanded
dynamic range should lead to significant further application
of myocardial contrast echocardiography .
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